Eko Murmur Analysis Software (EMAS) vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by RapidAI (formerly iSchemaView)

AI Verdict

Tool A, Eko Murmur Analysis Software, focuses on detecting and differentiating heart murmurs using digital stethoscope data for early disease detection. In contrast, Tool B, Rapid RV/LV, analyzes CTPA scans to rapidly assess pulmonary embolism severity by measuring ventricular ratios. While both are FDA-cleared cardiology AI tools, they address distinct diagnostic needs with different data inputs and clinical workflows.

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if your primary need is the early, non-invasive detection and differentiation of heart murmurs in both adult and pediatric patients. This tool is ideal for clinicians seeking AI-powered clinical decision support integrated with digital stethoscopes for routine screenings, follow-ups, or telehealth consultations, allowing for easy recording and sharing of heart sound data.

View Eko Murmur Analysis Software (EMAS) →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if you require a rapid, AI-powered assessment of pulmonary embolism severity from CTPA scans. This tool is best suited for emergency departments, radiology, and critical care settings where quick and objective measurement of RV/LV ratios is crucial for guiding immediate treatment decisions and reducing inter-rater variability in PE management.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Murmur Analysis Software (EMAS) Rapid RV/LV
Pricing Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. Contact vendor for pricing information.
Deployment Cloud-based, Mobile App On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Tool A, Eko Murmur Analysis Software, offers a cloud-based service accessed via a mobile application with wireless Bluetooth connectivity, suggesting a highly accessible and intuitive point-of-care experience for clinicians. In contrast, Tool B's on-premises or hybrid deployment, while efficient for radiology workflows, may involve more initial IT setup and less direct clinician interaction at the bedside.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in their respective specialized domains. EMAS aids in early detection and differentiation of heart murmurs in both adult and pediatric patients, while Rapid RV/LV offers rapid, objective assessment of pulmonary embolism severity by reducing inter-rater variability in critical care settings. Each addresses a vital clinical need with AI-powered decision support.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

Tool A, Eko Murmur Analysis Software, offers a transparent pricing model that includes a free tier for basic AI analysis with its mobile app, alongside paid subscriptions for full features and telehealth. This approach significantly lowers the barrier to entry and allows users to experience its value. Tool B, Rapid RV/LV, requires contacting the vendor for pricing information, which is less transparent.

Enterprise Readiness

Rapid RV/LV

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, establishing foundational enterprise readiness. However, Tool B's on-premises or hybrid deployment model, integration with a broader Rapid PE solution, and inclusion of triage and notification capabilities suggest a more robust and scalable solution designed for seamless integration into complex hospital IT infrastructures and existing radiology workflows. Tool A's cloud-based mobile app, while EHR compatible, may require more effort for large-scale enterprise deployment and management.

Innovation

Tie

Both tools demonstrate significant innovation by applying AI to critical clinical challenges. EMAS innovates by integrating AI with digital stethoscopes to augment traditional auscultation at the point of care, democratizing advanced diagnostic capabilities for early murmur detection. Rapid RV/LV innovates by automating and standardizing the rapid analysis of complex CTPA images for pulmonary embolism severity, which significantly impacts time-sensitive acute care decisions.

Support & Docs

Rapid RV/LV

RapidAI (Tool B) offers 24/7/365 customer support via email and phone globally, complemented by extensive online resources, guides, and FAQs. Eko Devices (Tool A) provides user manuals, FAQs, and email/phone support during business hours (Mon-Fri, 9 a.m. to 5 p.m. PT) for individual customers, with a separate help center for enterprise users. RapidAI's round-the-clock global support provides a more robust and responsive infrastructure, crucial for tools used in acute care settings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Murmur Analysis Software (EMAS) Rapid RV/LV
Tool Name Eko Murmur Analysis Software (EMAS) Rapid RV/LV
Company Eko Devices RapidAI (formerly iSchemaView)
Primary Modality/Input Heart sound (PCG) and optional ECG data from Eko digital stethoscopes. CTPA images.
Core AI Function Detect and differentiate heart murmurs (innocent and structural). Automated measurement of right and left ventricle ratios from CTPA scans for pulmonary embolism severity.
Target Patient Population Adult and pediatric patients. Not specified

Videos

Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and Rapid RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Murmur Analysis Software (EMAS) is designed for the early detection and differentiation of heart murmurs in adult and pediatric patients, providing clinical decision support for heart and lung disease. Rapid RV/LV by RapidAI focuses on the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
EMAS analyzes heart sound (PCG) and optional ECG data, which it integrates with Eko digital stethoscopes. Rapid RV/LV processes CTPA (Computed Tomography Pulmonary Angiography) images to perform its automated measurements.
EMAS is primarily utilized in Cardiology, Internal Medicine, and Pediatrics for heart and lung sound analysis. Rapid RV/LV supports Cardiology, Pulmonology, and Radiology, focusing on the analysis of CTPA images for pulmonary embolism.
EMAS provides FDA-cleared AI for murmur detection, differentiates innocent and structural heart murmurs, and generates PDF reports. Rapid RV/LV delivers automated measurements of right and left ventricle diameters, calculates the RV/LV ratio, and provides annotated images showing these ventricular measurements rapidly.

Backers

Who funded each tool's parent company.

Eko Murmur Analysis Software (EMAS)

AI Tool Finder
AI-powered search. Results may not be comprehensive.